Back to Dravet Syndrome

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

    AVAILABLE → NO LONGER AVAILABLE

    Recorded 2026-10-20

    View record
  2. Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS

    NOT YET RECRUITING → ENROLLING BY INVITATION

    Recorded 2026-10-11

    View record
  3. Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record